Alerts will be sent to your verified email
Verify Email
FERMENTA
|
Fermenta Biotech
|
Advanced Enzyme
|
Concord Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
3.99 % | 7.5 % | 2.26 % |
|
Financials
|
|||
|
5 yr Average ROE
|
2.37 % | 12.01 % | 20.02 % |
|
5yr average Equity Multiplier
|
1.97 | 1.16 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.42 | 0.52 |
|
5yr Avg Net Profit Margin
|
2.96 % | 24.34 % | 30.81 % |
|
Price to Book
|
2.95 | 2.48 | 10.83 |
|
P/E
|
24.06 | 25.02 | 52.8 |
|
5yr Avg Cash Conversion Cycle
|
23.64 Days | 87.24 Days | 37.41 Days |
|
Inventory Days
|
138.41 Days | 72.86 Days | 80.96 Days |
|
Days Receivable
|
60.61 Days | 58.11 Days | 111.87 Days |
|
Days Payable
|
136.91 Days | 50.65 Days | 173.13 Days |
|
5yr Average Interest Coverage Ratio
|
1.68 | 54.91 | 137.55 |
|
5yr Avg ROCE
|
8.67 % | 16.0 % | 25.59 % |
|
5yr Avg Operating Profit Margin
|
14.59 % | 38.48 % | 42.97 % |
|
5 yr average Debt to Equity
|
0.63 | 0.02 | 0.04 |
|
5yr CAGR Net Profit
|
n/a | 0.61 % | 12.77 % |
|
5yr Average Return on Assets
|
1.31 % | 10.35 % | 15.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.09 % | 43.08 % | 44.08 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.51 % | -9.62 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -1.1 % | -0.42 % |
|
Fermenta Biotech
|
Advanced Enzyme
|
Concord Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|